- Home
- XRTX vs SYTA Comparison
XRTX vs SYTA Comparison
Compare XRTX & SYTA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- XRTX
- SYTA
- Stock Information
- Founded
- XRTX 2011
- SYTA 1986
- Country
- XRTX Canada
- SYTA Canada
- Employees
- XRTX N/A
- SYTA N/A
- Industry
- XRTX Pharmaceuticals and Biotechnology
- SYTA Telecommunications Equipment
- Sector
- XRTX Health Care
- SYTA Telecommunications
- Exchange
- XRTX Nasdaq
- SYTA Nasdaq
- Market Cap
- XRTX 3.0M
- SYTA 3.1M
- IPO Year
- XRTX N/A
- SYTA 2020
- Fundamental
- Price
- XRTX $0.92
- SYTA $2.22
- Analyst Decision
- XRTX
- SYTA
- Analyst Count
- XRTX 0
- SYTA 0
- Target Price
- XRTX N/A
- SYTA N/A
- AVG Volume (30 Days)
- XRTX 84.2K
- SYTA 1.6M
- Earning Date
- XRTX 05-09-2025
- SYTA 04-07-2025
- Dividend Yield
- XRTX N/A
- SYTA N/A
- EPS Growth
- XRTX N/A
- SYTA N/A
- EPS
- XRTX N/A
- SYTA N/A
- Revenue
- XRTX N/A
- SYTA $11,988,979.00
- Revenue This Year
- XRTX N/A
- SYTA $75.92
- Revenue Next Year
- XRTX N/A
- SYTA $19.72
- P/E Ratio
- XRTX N/A
- SYTA N/A
- Revenue Growth
- XRTX N/A
- SYTA 41.59
- 52 Week Low
- XRTX $0.82
- SYTA $2.01
- 52 Week High
- XRTX $5.81
- SYTA $885.60
- Technical
- Relative Strength Index (RSI)
- XRTX 42.89
- SYTA 29.72
- Support Level
- XRTX $0.85
- SYTA $2.10
- Resistance Level
- XRTX $1.10
- SYTA $3.38
- Average True Range (ATR)
- XRTX 0.11
- SYTA 0.66
- MACD
- XRTX 0.00
- SYTA -0.00
- Stochastic Oscillator
- XRTX 11.63
- SYTA 1.43
About XRTX XORTX Therapeutics Inc.
XORTX Therapeutics Inc is a clinical-stage biotechnology company focused on identifying, developing, and potentially commercializing therapies to treat progressive kidney disease modulated by aberrant purine and uric acid metabolism and uric acid metabolism in orphan (rare) disease indications such as ADPKD and T2DN, as well as AKI associated with respiratory virus infection. Its focus is on developing three therapeutic products to slow or reverse the progression of chronic kidney disease, address the immediate need of individuals facing AKI associated with respiratory virus infection, and identify other opportunities where existing and new intellectual property can be leveraged to address health issues.
About SYTA Siyata Mobile Inc.
Siyata Mobile Inc is engaged in the sale of vehicle mounted, cellular-based communications platforms over advanced 3G (Third generation) mobile networks and cellular booster systems. The Company develops, markets and sells a portfolio of rugged handheld Push-to-Talk over Cellular (PoC) smartphone devices. These rugged business-to-business (B2B) environments are focused on enterprise customers, first responders, construction workers, security guards, government agencies, utilities, transportation and waste management, amusement parks, and mobile workers in multiple industries. The company operates in USA, Canada, EMEA and Australia. It derives maximum revenue from USA.